Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 17,654 | 20,147 | 15,129 | 12,405 | 12,386 |
| Cost of Goods | 8,058 | 9,191 | 7,487 | 5,538 | 5,132 |
| Gross Profit | 9,596 | 10,956 | 7,641 | 6,867 | 7,254 |
| Operating Expenses | 9,127 | 9,101 | 6,047 | 7,634 | 8,231 |
| Operating Income | 469 | 1,855 | 1,594 | -767 | -977 |
| Interest Expense | 2,426 | 2,363 | 1,451 | 1,770 | 1,524 |
| Other Income | 160 | -2,701 | -2,305 | 522 | 3,066 |
| Pre-tax Income | -1,797 | -3,208 | -2,162 | -2,015 | 566 |
| Income Tax | -282 | 275 | -926 | 0 | 69 |
| Net Income Continuous | -1,514 | -3,484 | -1,236 | -2,015 | 497 |
| Net Income | $-1,514 | $-3,484 | $-1,236 | $-2,015 | $497 |
| EPS Basic Total Ops | -0.10 | -0.24 | -0.09 | -0.15 | 0.04 |
| EPS Basic Continuous Ops | -0.10 | -0.24 | -0.09 | -0.15 | 0.04 |
| EPS Diluted Total Ops | -0.10 | -0.24 | -0.09 | -0.15 | 0.04 |
| EPS Diluted Continuous Ops | -0.10 | -0.24 | -0.09 | -0.15 | 0.04 |
| EBITDA(a) | $2,103 | $630 | $149 | $777 | $3,045 |